Goodwill of BIOGEN INC. from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
BIOGEN INC. quarterly Goodwill in USD history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • BIOGEN INC. Goodwill for the quarter ending 30 Sep 2025 was $6,490,700,000, a 0.08% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

BIOGEN INC. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,490,700,000 +$4,900,000 +0.08% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $6,493,100,000 +$265,700,000 +4.3% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $6,477,100,000 +$249,700,000 +4% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $6,478,900,000 +$259,700,000 +4.2% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $6,485,800,000 -$321,700,000 -4.7% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $6,227,400,000 +$473,700,000 +8.2% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $6,227,400,000 +$475,600,000 +8.3% 31 Mar 2024 10-Q 24 Apr 2024 2024 Q1
Q4 2023 $6,219,200,000 +$470,200,000 +8.2% 31 Dec 2023 10-K 12 Feb 2025 2024 FY
Q3 2023 $6,807,500,000 +$1,066,300,000 +19% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $5,753,700,000 +$4,100,000 +0.07% 30 Jun 2023 10-Q 25 Jul 2023 2023 Q2
Q1 2023 $5,751,800,000 -$6,200,000 -0.11% 31 Mar 2023 10-Q 25 Apr 2023 2023 Q1
Q4 2022 $5,749,000,000 -$12,100,000 -0.21% 31 Dec 2022 10-K 12 Feb 2025 2024 FY
Q3 2022 $5,741,200,000 -$19,300,000 -0.34% 30 Sep 2022 10-Q 25 Oct 2022 2022 Q3
Q2 2022 $5,749,600,000 -$14,300,000 -0.25% 30 Jun 2022 10-Q 20 Jul 2022 2022 Q1
Q1 2022 $5,758,000,000 -$5,100,000 -0.09% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $5,761,100,000 -$1,000,000 -0.02% 31 Dec 2021 10-K 14 Feb 2024 2023 FY
Q3 2021 $5,760,500,000 +$4,800,000 +0.08% 30 Sep 2021 10-Q 20 Oct 2021 2021 Q3
Q2 2021 $5,763,900,000 +$12,900,000 +0.22% 30 Jun 2021 10-Q 22 Jul 2021 2021 Q2
Q1 2021 $5,763,100,000 +$11,100,000 +0.19% 31 Mar 2021 10-Q 22 Apr 2021 2021 Q1
Q4 2020 $5,762,100,000 +$4,300,000 +0.08% 31 Dec 2020 10-K 15 Feb 2023 2022 FY
Q3 2020 $5,755,700,000 +$9,600,000 +0.17% 30 Sep 2020 10-Q 21 Oct 2020 2020 Q3
Q2 2020 $5,751,000,000 +$1,800,000 +0.03% 30 Jun 2020 10-Q 22 Jul 2020 2020 Q2
Q1 2020 $5,752,000,000 +$112,300,000 +2% 31 Mar 2020 10-Q 23 Apr 2020 2020 Q1
Q4 2019 $5,757,800,000 +$51,400,000 +0.9% 31 Dec 2019 10-K 03 Feb 2022 2021 FY
Q3 2019 $5,746,100,000 +$306,000,000 +5.6% 30 Sep 2019 10-Q 22 Oct 2019 2019 Q3
Q2 2019 $5,749,200,000 +$578,900,000 +11% 30 Jun 2019 10-Q 24 Jul 2019 2019 Q2
Q1 2019 $5,639,700,000 +$731,900,000 +15% 31 Mar 2019 10-Q 24 Apr 2019 2019 Q1
Q4 2018 $5,706,400,000 +$1,073,900,000 +23% 31 Dec 2018 10-K 03 Feb 2021 2020 FY
Q3 2018 $5,440,100,000 +$1,312,600,000 +32% 30 Sep 2018 10-Q 23 Oct 2018 2018 Q3
Q2 2018 $5,170,300,000 +$1,299,900,000 +34% 30 Jun 2018 10-Q 24 Jul 2018 2018 Q2
Q1 2018 $4,907,800,000 +$1,296,100,000 +36% 31 Mar 2018 10-Q 24 Apr 2018 2018 Q1
Q4 2017 $4,632,500,000 +$963,200,000 +26% 31 Dec 2017 10-K 06 Feb 2020 2019 FY
Q3 2017 $4,127,500,000 +$707,800,000 +21% 30 Sep 2017 10-Q 24 Oct 2017 2017 Q3
Q2 2017 $3,870,400,000 +$703,300,000 +22% 30 Jun 2017 10-Q 25 Jul 2017 2017 Q2
Q1 2017 $3,611,700,000 +$693,800,000 +24% 31 Mar 2017 10-Q 25 Apr 2017 2017 Q1
Q4 2016 $3,669,300,000 +$1,005,500,000 +38% 31 Dec 2016 10-K 06 Feb 2019 2018 FY
Q3 2016 $3,419,700,000 +$1,010,846,000 +42% 30 Sep 2016 10-Q 26 Oct 2016 2016 Q3
Q2 2016 $3,167,100,000 +$1,012,759,000 +47% 30 Jun 2016 10-Q 21 Jul 2016 2016 Q2
Q1 2016 $2,917,900,000 +$1,068,048,000 +58% 31 Mar 2016 10-Q 21 Apr 2016 2016 Q1
Q4 2015 $2,663,800,000 +$903,600,000 +51% 31 Dec 2015 10-K 01 Feb 2018 2017 FY
Q3 2015 $2,408,854,000 +$867,650,000 +56% 30 Sep 2015 10-Q 21 Oct 2015 2015 Q3
Q2 2015 $2,154,341,000 +$789,526,000 +58% 30 Jun 2015 10-Q 24 Jul 2015 2015 Q2
Q1 2015 $1,849,852,000 +$616,936,000 +50% 31 Mar 2015 10-Q 24 Apr 2015 2015 Q1
Q4 2014 $1,760,200,000 +$527,300,000 +43% 31 Dec 2014 10-K 02 Feb 2017 2016 FY
Q3 2014 $1,541,204,000 +$330,486,000 +27% 30 Sep 2014 10-Q 22 Oct 2014 2014 Q3
Q2 2014 $1,364,815,000 +$154,097,000 +13% 30 Jun 2014 10-Q 23 Jul 2014 2014 Q2
Q1 2014 $1,232,916,000 +$22,198,000 +1.8% 31 Mar 2014 10-Q 23 Apr 2014 2014 Q1
Q4 2013 $1,232,900,000 +$31,600,000 +2.6% 31 Dec 2013 10-K 03 Feb 2016 2015 FY
Q3 2013 $1,210,718,000 +$5,978,000 +0.5% 30 Sep 2013 10-Q 28 Oct 2013 2013 Q3
Q2 2013 $1,210,718,000 +$12,814,000 +1.1% 30 Jun 2013 10-Q 25 Jul 2013 2013 Q2
Q1 2013 $1,210,718,000 +$17,439,000 +1.5% 31 Mar 2013 10-Q 25 Apr 2013 2013 Q1
Q4 2012 $1,201,300,000 +$55,000,000 +4.8% 31 Dec 2012 10-K 04 Feb 2015 2014 FY
Q3 2012 $1,204,740,000 +$58,426,000 +5.1% 30 Sep 2012 10-Q 25 Oct 2012 2012 Q3
Q2 2012 $1,197,904,000 +$51,590,000 +4.5% 30 Jun 2012 10-Q 24 Jul 2012 2012 Q2
Q1 2012 $1,193,279,000 +$46,965,000 +4.1% 31 Mar 2012 10-Q 01 May 2012 2012 Q1
Q4 2011 $1,146,300,000 -$14,000 -0% 31 Dec 2011 10-K 06 Feb 2014 2013 FY
Q3 2011 $1,146,314,000 +$7,693,000 +0.68% 30 Sep 2011 10-Q 28 Oct 2011 2011 Q3
Q2 2011 $1,146,314,000 +$7,693,000 +0.68% 30 Jun 2011 10-Q 26 Jul 2011 2011 Q2
Q1 2011 $1,146,314,000 +$7,693,000 +0.68% 31 Mar 2011 10-Q 21 Apr 2011 2011 Q1
Q4 2010 $1,146,314,000 31 Dec 2010 10-K 05 Feb 2013 2012 FY
Q3 2010 $1,138,621,000 30 Sep 2010 10-Q 26 Oct 2010 2010 Q3
Q2 2010 $1,138,621,000 30 Jun 2010 10-Q 20 Jul 2010 2010 Q2
Q1 2010 $1,138,621,000 31 Mar 2010 10-Q 20 Apr 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.